Unilever

Company snapshot

Every day, 3.4 billion people around the world enjoy our products - from ground-breaking brands like Hellmann's, Domestos, Dove and Rexona (to name just a few). Our brands lead the way - innovating in their fields, delighting their consumers and powering our business forward. And it is our people who make everything happen. Our bright and curious people who imagine and create the future - diverse,

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Unilever. Not investment advice.

• What is Unilever?

  Unilever Australia is a pharma organization headquartered in AU. Primary therapeutic focus areas include Cognition. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Unilever publicly traded?

  Unilever appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Unilever develop or market?

  No drug profiles are currently linked to Unilever. Pipeline programs may still list investigational assets.

• What are the latest developments for Unilever?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Unilever focus on?

  Unilever focuses on Cognition based on our analysis of their pipeline programs and drug development activities.